Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025 AACR 3 Mins Read Introduction The KEYNOTE-689 clinical trial has provided a significant update on pembrolizumab’s role in treating resectable locally advanced head and…
